Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC40H56 |
InChIKeyOAIJSZIZWZSQBC-GYZMGTAESA-N |
CAS Registry502-65-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Syndrome | Phase 3 | Lebanon | 31 Jan 2011 | |
| Carcinogenesis | Phase 2 | Italy | 03 Aug 2016 | |
| Colorectal Cancer | Phase 2 | Italy | 03 Aug 2016 | |
| Folliculitis | Phase 2 | Italy | 03 Aug 2016 | |
| Paronychia | Phase 2 | Italy | 03 Aug 2016 | |
| Inflammation | Phase 2 | Italy | 03 Aug 2016 | |
| Prostatitis | Phase 2 | United States | 29 Feb 2008 | |
| Prostatic Cancer | Phase 2 | United States | 01 Feb 2006 | |
| Prostatic Intraepithelial Neoplasia | Phase 2 | United States | 01 Feb 2006 | |
| Metastatic Prostate Carcinoma | Phase 2 | United States | 31 Jan 2004 |
Phase 2 | 14 | jrumgwmcaq(qsaqbyjhgq) = ogyolhjdjn jilmgxcdnv (szrrxrpzcb, 350.1) View more | - | 04 Jun 2018 | |||
Phase 2 | 66 | (Lycopene) | mrcbquljpf(gozirfpefd) = vyhynplczl ocwcfcfsdz (xxyxsjyyqt, gnanvtwdng - mjflwfsoor) View more | - | 04 Jun 2015 | ||
Placebo (Placebo) | mrcbquljpf(gozirfpefd) = wrkseyhbib ocwcfcfsdz (xxyxsjyyqt, zvhflpllkn - rqufvqxear) View more | ||||||
Phase 2 | - | LycoMato® capsules | mptwzfihlv(qgcmauygja) = cxzltzvcbt dexeongnok (qjxkdsamzf ) | - | 15 Apr 2012 | ||
Phase 2 | Castration-Resistant Prostatic Cancer serum prostate-specific antigen elevation | 46 | jtjtzubrtn(bfstsailkp) = 1 patient died of a cancer-related hemorrhage xogiymwlyh (azgnagrspa ) | Negative | 01 Feb 2007 |





